KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Cash from Restructuring (2016 - 2017)

Vertex Pharmaceuticals has reported Cash from Restructuring over the past 9 years, most recently at -$2.1 million for Q4 2017.

  • Quarterly results put Cash from Restructuring at -$2.1 million for Q4 2017, down 392.97% from a year ago — trailing twelve months through Dec 2017 was -$6.0 million (up 19.38% YoY), and the annual figure for FY2017 was -$6.0 million, up 19.38%.
  • Cash from Restructuring for Q4 2017 was -$2.1 million at Vertex Pharmaceuticals, up from -$2.8 million in the prior quarter.
  • Over the last five years, Cash from Restructuring for VRTX hit a ceiling of $36.6 million in Q3 2014 and a floor of -$24.4 million in Q1 2015.
  • Median Cash from Restructuring over the past 5 years was -$1.6 million (2015), compared with a mean of -$1.1 million.
  • Peak annual rise in Cash from Restructuring hit 796.18% in 2014, while the deepest fall reached 1099.75% in 2014.
  • Vertex Pharmaceuticals' Cash from Restructuring stood at $2.2 million in 2013, then tumbled by 540.05% to -$9.7 million in 2014, then skyrocketed by 74.96% to -$2.4 million in 2015, then skyrocketed by 129.7% to $725000.0 in 2016, then tumbled by 392.97% to -$2.1 million in 2017.
  • The last three reported values for Cash from Restructuring were -$2.1 million (Q4 2017), -$2.8 million (Q3 2017), and -$1.4 million (Q2 2017) per Business Quant data.